Sofia Ioannidou serves as Executive at LogicBio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Sofia Ioannidou has executed 2 insider transactions totaling $4.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 23, 2018 involved purchasing 420,000 shares valued at $4.2M.
Sofia Ioannidou currently holds 1,787,413 shares of LogicBio Therapeutics, Inc. (LOGC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sofia Ioannidou has been a net buyer of LOGC stock. They have purchased $4.2M and sold $0 worth of shares.
Sofia Ioannidou's most recent insider trade was on Oct 23, 2018, when they purchased 420,000 shares at $10.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |